{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:09:28Z","timestamp":1780535368596,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1136\/ard.2009.113092","type":"journal-article","created":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:13:41Z","timestamp":1249085621000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study"],"prefix":"10.1016","volume":"69","author":[{"given":"S W","family":"Syversen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G L","family":"Goll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"van der Heijde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Landew\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B A","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"\u00d8deg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P I","family":"Gaarder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T K","family":"Kvien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.113092_bib1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.22353","article-title":"Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis.","volume":"55","author":"Finckh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib2","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","article-title":"The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib3","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.23618","article-title":"Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.","volume":"58","author":"Kinloch","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.21739","article-title":"The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.","volume":"54","author":"van der Helm-van Mil","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib5","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.","volume":"116","author":"Kuhn","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2009.113092_bib7","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/art.23127","article-title":"Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.","volume":"56","author":"Verpoort","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib8","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/art.23763","article-title":"Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.","volume":"58","author":"Ioan-Facsinay","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","article-title":"Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.","volume":"65","author":"Berglin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","article-title":"Prognostic laboratory markers of joint damage in rheumatoid arthritis.","volume":"64","author":"Lindqvist","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ard.2004.029389","article-title":"Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.","volume":"64","author":"Nielen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib13","doi-asserted-by":"crossref","unstructured":"Luime JJ, Colin EM, Hazes JM, et al. Does anti-MCV has additional value as serological marker in the diagnostic and prognostic work-up of patients with rheumatoid arthritis? A systematic review. Ann Rheum Dis. Published Online First 15 March 2009. doi:10.1136\/ard.2008.103283","DOI":"10.1136\/ard.2008.103283"},{"key":"10.1136\/ard.2009.113092_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","article-title":"Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.","volume":"46","author":"Machold","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.113092_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","article-title":"High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.","volume":"67","author":"Syversen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib17","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113092_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ncb898","article-title":"Vimentin is secreted by activated macrophages.","volume":"5","author":"Mor-Vaknin","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1136\/ard.2009.113092_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2009.113092_bib20","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.23188","article-title":"Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.","volume":"58","author":"Mathsson","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib22","first-page":"1658","article-title":"Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.","volume":"34","author":"Soos","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113092_bib23","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar2570","article-title":"Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.","volume":"10","author":"Roland","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113092_bib24","first-page":"1002","article-title":"Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.","volume":"35","author":"Innala","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113092_bib25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","article-title":"Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis.","volume":"53","author":"Coenen","year":"2007","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2009.113092_bib26","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2008","article-title":"Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.","volume":"8","author":"Dejaco","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113092_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","article-title":"Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.","volume":"34","author":"Poulsom","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1136\/ard.2009.113092_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.21548","article-title":"Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients.","volume":"54","author":"\u00d8deg\u00e5rd","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib29","first-page":"2218","article-title":"Life events, psychosocial factors, and demographic variables in early rheumatoid arthritis: relations to one-year changes in functional disability.","volume":"22","author":"Smedstad","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113092_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib31","first-page":"261","article-title":"How to read radiographs according to the Sharp\/van der Heijde method.","volume":"27","author":"van der Heijde","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113092_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard.2007.085985","article-title":"Cortical hand bone loss after one year in early rheumatoid arthritis predicts radiographic hand joint damage at 5 and 10 year follow-up.","volume":"68","author":"Hoff","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/ard.2006.067892","article-title":"Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study.","volume":"66","author":"Lie","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.berh.2004.08.008","article-title":"How to predict prognosis in early rheumatoid arthritis.","volume":"19","author":"Morel","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/ard.2009.113092_bib35","first-page":"8","article-title":"Predictive markers in rapidly progressing rheumatoid arthritis.","volume":"80","author":"Landewe","year":"2007","journal-title":"J Rheumatol Suppl"},{"key":"10.1136\/ard.2009.113092_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2418","article-title":"The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?","volume":"10","author":"Smolen","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113092_bib37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/art.23439","article-title":"Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.","volume":"58","author":"de Vries-Bouwstra","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113092_bib38","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2008.094128","article-title":"Progression of radiographic joint damage in rheumatoid arthritis: Independence of erosions and joint space narrowing.","volume":"68","author":"Smolen","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113092_bib39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2119\/molmed.2009.00008","article-title":"Genome wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis.","volume":"15","author":"Cui","year":"2009","journal-title":"Mol Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.113092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:53:45Z","timestamp":1737528825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724196197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0003496724196197"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.113092","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.113092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Publishing Group Ltd and European League Against Rheumatism. All rights reserved. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}